Skip to content

  ( )

ChemoTech
When life science matters
ChemoTechChemoTech
+46 (0)10 218 93 00[email protected]
Facebook page opens in new windowTwitter page opens in new windowYouTube page opens in new windowLinkedin page opens in new window
  • About ChemoTech
    • About ChemoTech
    • Company Management
    • Events
    • Career
  • Our Products
  • Publications
    • ChemoTech Publications
    • General Publications
    • Clinical Guidelines
  • News & Press Releases
    • Svenska
    • English
  • Investors
    • Investor Relations
    • IPO/Share Issue Documents
    • Financial Reports
    • Financial Analysis
    • Financial Calendar
    • Shareholders Meetings
    • Presentations
  • Contact
  • Vetiqure
  • About ChemoTech
    • About ChemoTech
    • Company Management
    • Events
    • Career
  • Our Products
  • Publications
    • ChemoTech Publications
    • General Publications
    • Clinical Guidelines
  • News & Press Releases
    • Svenska
    • English
  • Investors
    • Investor Relations
    • IPO/Share Issue Documents
    • Financial Reports
    • Financial Analysis
    • Financial Calendar
    • Shareholders Meetings
    • Presentations
  • Contact
  • Vetiqure

Daily Archives: 2 February, 2017

You are here:
  1. Home
  2. 2017
  3. February
  4. 02

Scandinavian ChemoTech AB (publ) signed their second LOI in the Philippines

Press ReleasesBy martin2 February, 2017

Press release Lund February 2, 2017 Scandinavian ChemoTech AB (publ) signed their second LOI in the Philippines On Februrary 1st 2017 ChemoTech wrote their second Letter of Intent in the Philippines. This LOI was signed with Makati Medical Center (“MMC”) in Manila. According to the agreement, MCC are to conduct and assess treatments with the…

Go to Top